 | • レポートコード：GIR-2104Z09535 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、分子細胞遺伝学のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。分子細胞遺伝学の種類別市場規模（非放射性in situハイブリダイゼーション、比較ゲノムハイブリダイゼーション、in situハイブリダイゼーション）、用途別市場規模（製薬・バイオテクノロジー企業、学術研究機関、病院・診断センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・分子細胞遺伝学の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、Agilent Technologies、Applied Spectral Imaging、Bio-Rad Laboratories、Danaher、Illumina、Oxford Gene Technology、Perkinelmer、F. Hoffmann-La Roche、Thermo Fisher Scientific ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：非放射性in situハイブリダイゼーション、比較ゲノムハイブリダイゼーション、in situハイブリダイゼーション ・用途別分析2016年-2026年：製薬・バイオテクノロジー企業、学術研究機関、病院・診断センター、その他 ・分子細胞遺伝学の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・分子細胞遺伝学のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・分子細胞遺伝学のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・分子細胞遺伝学の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・分子細胞遺伝学の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Molecular Cytogenetics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Molecular Cytogenetics size is estimated to be USD 2083.4 million in 2025 from USD 1546.6 million in 2019, with a change XX% between 2019 and 2020. The global Molecular Cytogenetics market size is expected to grow at a CAGR of 7.7% for the next five years.
Market segmentation
Molecular Cytogenetics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Non-Radioactive In Situ Hybridization
Comparative Genomic Hybridization
In Situ Hybridization
Market segment by Application, can be divided into
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospitals and Diagnostic Centers
Other
Market segment by players, this report covers
Abbott Laboratories
Agilent Technologies
Applied Spectral Imaging
Bio-Rad Laboratories
Danaher
Illumina
Oxford Gene Technology
Perkinelmer
F. Hoffmann-La Roche
Thermo Fisher Scientific
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Molecular Cytogenetics
1.2 Classification of Molecular Cytogenetics by Type
1.2.1 Overview: Global Molecular Cytogenetics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Molecular Cytogenetics Revenue Market Share by Type in 2020
1.2.3 Non-Radioactive In Situ Hybridization
1.2.4 Comparative Genomic Hybridization
1.2.5 In Situ Hybridization
1.3 Global Molecular Cytogenetics Market by Application
1.3.1 Overview: Global Molecular Cytogenetics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic and Research Institutes
1.3.4 Hospitals and Diagnostic Centers
1.3.5 Other
1.4 Global Molecular Cytogenetics Market Size & Forecast
1.5 Global Molecular Cytogenetics Market Size and Forecast by Region
1.5.1 Global Molecular Cytogenetics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Molecular Cytogenetics Market Size by Region, (2016-2021)
1.5.3 North America Molecular Cytogenetics Market Size and Prospect (2016-2026)
1.5.4 Europe Molecular Cytogenetics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Molecular Cytogenetics Market Size and Prospect (2016-2026)
1.5.6 South America Molecular Cytogenetics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Molecular Cytogenetics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Molecular Cytogenetics Market Drivers
1.6.2 Molecular Cytogenetics Market Restraints
1.6.3 Molecular Cytogenetics Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Molecular Cytogenetics Product and Solutions
2.1.4 Abbott Laboratories Molecular Cytogenetics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Agilent Technologies
2.2.1 Agilent Technologies Details
2.2.2 Agilent Technologies Major Business
2.2.3 Agilent Technologies Molecular Cytogenetics Product and Solutions
2.2.4 Agilent Technologies Molecular Cytogenetics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Agilent Technologies Recent Developments and Future Plans
2.3 Applied Spectral Imaging
2.3.1 Applied Spectral Imaging Details
2.3.2 Applied Spectral Imaging Major Business
2.3.3 Applied Spectral Imaging Molecular Cytogenetics Product and Solutions
2.3.4 Applied Spectral Imaging Molecular Cytogenetics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Applied Spectral Imaging Recent Developments and Future Plans
2.4 Bio-Rad Laboratories
2.4.1 Bio-Rad Laboratories Details
2.4.2 Bio-Rad Laboratories Major Business
2.4.3 Bio-Rad Laboratories Molecular Cytogenetics Product and Solutions
2.4.4 Bio-Rad Laboratories Molecular Cytogenetics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.5 Danaher
2.5.1 Danaher Details
2.5.2 Danaher Major Business
2.5.3 Danaher Molecular Cytogenetics Product and Solutions
2.5.4 Danaher Molecular Cytogenetics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Danaher Recent Developments and Future Plans
2.6 Illumina
2.6.1 Illumina Details
2.6.2 Illumina Major Business
2.6.3 Illumina Molecular Cytogenetics Product and Solutions
2.6.4 Illumina Molecular Cytogenetics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Illumina Recent Developments and Future Plans
2.7 Oxford Gene Technology
2.7.1 Oxford Gene Technology Details
2.7.2 Oxford Gene Technology Major Business
2.7.3 Oxford Gene Technology Molecular Cytogenetics Product and Solutions
2.7.4 Oxford Gene Technology Molecular Cytogenetics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Oxford Gene Technology Recent Developments and Future Plans
2.8 Perkinelmer
2.8.1 Perkinelmer Details
2.8.2 Perkinelmer Major Business
2.8.3 Perkinelmer Molecular Cytogenetics Product and Solutions
2.8.4 Perkinelmer Molecular Cytogenetics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Perkinelmer Recent Developments and Future Plans
2.9 F. Hoffmann-La Roche
2.9.1 F. Hoffmann-La Roche Details
2.9.2 F. Hoffmann-La Roche Major Business
2.9.3 F. Hoffmann-La Roche Molecular Cytogenetics Product and Solutions
2.9.4 F. Hoffmann-La Roche Molecular Cytogenetics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.10 Thermo Fisher Scientific
2.10.1 Thermo Fisher Scientific Details
2.10.2 Thermo Fisher Scientific Major Business
2.10.3 Thermo Fisher Scientific Molecular Cytogenetics Product and Solutions
2.10.4 Thermo Fisher Scientific Molecular Cytogenetics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Thermo Fisher Scientific Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Molecular Cytogenetics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Molecular Cytogenetics Players Market Share
3.2.2 Top 10 Molecular Cytogenetics Players Market Share
3.2.3 Market Competition Trend
3.3 Molecular Cytogenetics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Molecular Cytogenetics Revenue and Market Share by Type (2016-2021)
4.2 Global Molecular Cytogenetics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Molecular Cytogenetics Revenue Market Share by Application (2016-2021)
5.2 Molecular Cytogenetics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Molecular Cytogenetics Revenue by Type (2016-2026)
6.2 North America Molecular Cytogenetics Revenue by Application (2016-2026)
6.3 North America Molecular Cytogenetics Market Size by Country
6.3.1 North America Molecular Cytogenetics Revenue by Country (2016-2026)
6.3.2 United States Molecular Cytogenetics Market Size and Forecast (2016-2026)
6.3.3 Canada Molecular Cytogenetics Market Size and Forecast (2016-2026)
6.3.4 Mexico Molecular Cytogenetics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Molecular Cytogenetics Revenue by Type (2016-2026)
7.2 Europe Molecular Cytogenetics Revenue by Application (2016-2026)
7.3 Europe Molecular Cytogenetics Market Size by Country
7.3.1 Europe Molecular Cytogenetics Revenue by Country (2016-2026)
7.3.2 Germany Molecular Cytogenetics Market Size and Forecast (2016-2026)
7.3.3 France Molecular Cytogenetics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Molecular Cytogenetics Market Size and Forecast (2016-2026)
7.3.5 Russia Molecular Cytogenetics Market Size and Forecast (2016-2026)
7.3.6 Italy Molecular Cytogenetics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Molecular Cytogenetics Revenue by Type (2016-2026)
8.2 Asia-Pacific Molecular Cytogenetics Revenue by Application (2016-2026)
8.3 Asia-Pacific Molecular Cytogenetics Market Size by Region
8.3.1 Asia-Pacific Molecular Cytogenetics Revenue by Region (2016-2026)
8.3.2 China Molecular Cytogenetics Market Size and Forecast (2016-2026)
8.3.3 Japan Molecular Cytogenetics Market Size and Forecast (2016-2026)
8.3.4 South Korea Molecular Cytogenetics Market Size and Forecast (2016-2026)
8.3.5 India Molecular Cytogenetics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Molecular Cytogenetics Market Size and Forecast (2016-2026)
8.3.7 Australia Molecular Cytogenetics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Molecular Cytogenetics Revenue by Type (2016-2026)
9.2 South America Molecular Cytogenetics Revenue by Application (2016-2026)
9.3 South America Molecular Cytogenetics Market Size by Country
9.3.1 South America Molecular Cytogenetics Revenue by Country (2016-2026)
9.3.2 Brazil Molecular Cytogenetics Market Size and Forecast (2016-2026)
9.3.3 Argentina Molecular Cytogenetics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Molecular Cytogenetics Revenue by Type (2016-2026)
10.2 Middle East & Africa Molecular Cytogenetics Revenue by Application (2016-2026)
10.3 Middle East & Africa Molecular Cytogenetics Market Size by Country
10.3.1 Middle East & Africa Molecular Cytogenetics Revenue by Country (2016-2026)
10.3.2 Turkey Molecular Cytogenetics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Molecular Cytogenetics Market Size and Forecast (2016-2026)
10.3.4 UAE Molecular Cytogenetics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Molecular Cytogenetics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Molecular Cytogenetics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Molecular Cytogenetics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Molecular Cytogenetics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Molecular Cytogenetics Revenue Market Share by Region (2021-2026)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Molecular Cytogenetics Product and Solutions
Table 9. Abbott Laboratories Molecular Cytogenetics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 11. Agilent Technologies Major Business
Table 12. Agilent Technologies Molecular Cytogenetics Product and Solutions
Table 13. Agilent Technologies Molecular Cytogenetics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Applied Spectral Imaging Corporate Information, Head Office, and Major Competitors
Table 15. Applied Spectral Imaging Major Business
Table 16. Applied Spectral Imaging Molecular Cytogenetics Product and Solutions
Table 17. Applied Spectral Imaging Molecular Cytogenetics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 19. Bio-Rad Laboratories Major Business
Table 20. Bio-Rad Laboratories Molecular Cytogenetics Product and Solutions
Table 21. Bio-Rad Laboratories Molecular Cytogenetics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Danaher Corporate Information, Head Office, and Major Competitors
Table 23. Danaher Major Business
Table 24. Danaher Molecular Cytogenetics Product and Solutions
Table 25. Danaher Molecular Cytogenetics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Illumina Corporate Information, Head Office, and Major Competitors
Table 27. Illumina Major Business
Table 28. Illumina Molecular Cytogenetics Product and Solutions
Table 29. Illumina Molecular Cytogenetics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Oxford Gene Technology Corporate Information, Head Office, and Major Competitors
Table 31. Oxford Gene Technology Major Business
Table 32. Oxford Gene Technology Molecular Cytogenetics Product and Solutions
Table 33. Oxford Gene Technology Molecular Cytogenetics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Perkinelmer Corporate Information, Head Office, and Major Competitors
Table 35. Perkinelmer Major Business
Table 36. Perkinelmer Molecular Cytogenetics Product and Solutions
Table 37. Perkinelmer Molecular Cytogenetics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 39. F. Hoffmann-La Roche Major Business
Table 40. F. Hoffmann-La Roche Molecular Cytogenetics Product and Solutions
Table 41. F. Hoffmann-La Roche Molecular Cytogenetics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 43. Thermo Fisher Scientific Major Business
Table 44. Thermo Fisher Scientific Molecular Cytogenetics Product and Solutions
Table 45. Thermo Fisher Scientific Molecular Cytogenetics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Molecular Cytogenetics Revenue (USD Million) by Players (2019-2021)
Table 47. Global Molecular Cytogenetics Revenue Share by Players (2019-2021)
Table 48. Breakdown of Molecular Cytogenetics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Molecular Cytogenetics Players Head Office, Products and Services Provided
Table 50. Molecular Cytogenetics Mergers & Acquisitions in the Past Five Years
Table 51. Molecular Cytogenetics New Entrants and Expansion Plans
Table 52. Global Molecular Cytogenetics Revenue (USD Million) by Type (2016-2021)
Table 53. Global Molecular Cytogenetics Revenue Share by Type (2016-2021)
Table 54. Global Molecular Cytogenetics Revenue Forecast by Type (2021-2026)
Table 55. Global Molecular Cytogenetics Revenue by Application (2016-2021)
Table 56. Global Molecular Cytogenetics Revenue Forecast by Application (2021-2026)
Table 57. North America Molecular Cytogenetics Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Molecular Cytogenetics Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Molecular Cytogenetics Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Molecular Cytogenetics Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Molecular Cytogenetics Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Molecular Cytogenetics Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Molecular Cytogenetics Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Molecular Cytogenetics Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Molecular Cytogenetics Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Molecular Cytogenetics Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Molecular Cytogenetics Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Molecular Cytogenetics Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Molecular Cytogenetics Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Molecular Cytogenetics Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Molecular Cytogenetics Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Molecular Cytogenetics Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Molecular Cytogenetics Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Molecular Cytogenetics Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Molecular Cytogenetics Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Molecular Cytogenetics Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Molecular Cytogenetics Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Molecular Cytogenetics Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Molecular Cytogenetics Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Molecular Cytogenetics Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Molecular Cytogenetics Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Molecular Cytogenetics Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Molecular Cytogenetics Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Molecular Cytogenetics Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Molecular Cytogenetics Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Molecular Cytogenetics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Molecular Cytogenetics Picture
Figure 2. Global Molecular Cytogenetics Revenue Market Share by Type in 2020
Figure 3. Non-Radioactive In Situ Hybridization
Figure 4. Comparative Genomic Hybridization
Figure 5. In Situ Hybridization
Figure 6. Molecular Cytogenetics Revenue Market Share by Application in 2020
Figure 7. Pharmaceutical and Biotechnology Companies Picture
Figure 8. Academic and Research Institutes Picture
Figure 9. Hospitals and Diagnostic Centers Picture
Figure 10. Other Picture
Figure 11. Global Molecular Cytogenetics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Molecular Cytogenetics Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Molecular Cytogenetics Revenue Market Share by Region (2016-2026)
Figure 14. Global Molecular Cytogenetics Revenue Market Share by Region in 2020
Figure 15. North America Molecular Cytogenetics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Molecular Cytogenetics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Molecular Cytogenetics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Molecular Cytogenetics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Molecular Cytogenetics Market Drivers
Figure 20. Molecular Cytogenetics Market Restraints
Figure 21. Molecular Cytogenetics Market Trends
Figure 22. Abbott Laboratories Recent Developments and Future Plans
Figure 23. Agilent Technologies Recent Developments and Future Plans
Figure 24. Applied Spectral Imaging Recent Developments and Future Plans
Figure 25. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 26. Danaher Recent Developments and Future Plans
Figure 27. Illumina Recent Developments and Future Plans
Figure 28. Oxford Gene Technology Recent Developments and Future Plans
Figure 29. Perkinelmer Recent Developments and Future Plans
Figure 30. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 31. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 33. Global Molecular Cytogenetics Revenue Share by Players in 2020
Figure 34. Molecular Cytogenetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Molecular Cytogenetics Revenue Market Share in 2020
Figure 36. Global Top 10 Players Molecular Cytogenetics Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Molecular Cytogenetics Revenue Share by Type in 2020
Figure 39. Global Molecular Cytogenetics Market Share Forecast by Type (2021-2026)
Figure 40. Global Molecular Cytogenetics Revenue Share by Application in 2020
Figure 41. Global Molecular Cytogenetics Market Share Forecast by Application (2021-2026)
Figure 42. North America Molecular Cytogenetics Sales Market Share by Type (2016-2026)
Figure 43. North America Molecular Cytogenetics Sales Market Share by Application (2016-2026)
Figure 44. North America Molecular Cytogenetics Revenue Market Share by Country (2016-2026)
Figure 45. United States Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Molecular Cytogenetics Sales Market Share by Type (2016-2026)
Figure 49. Europe Molecular Cytogenetics Sales Market Share by Application (2016-2026)
Figure 50. Europe Molecular Cytogenetics Revenue Market Share by Country (2016-2026)
Figure 51. Germany Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Molecular Cytogenetics Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Molecular Cytogenetics Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Molecular Cytogenetics Revenue Market Share by Region (2016-2026)
Figure 59. China Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Molecular Cytogenetics Sales Market Share by Type (2016-2026)
Figure 66. South America Molecular Cytogenetics Sales Market Share by Application (2016-2026)
Figure 67. South America Molecular Cytogenetics Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Molecular Cytogenetics Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Molecular Cytogenetics Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Molecular Cytogenetics Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Molecular Cytogenetics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の分子細胞遺伝市場規模・現状・予測（2021年-2027年） The global molecular cytogenetics market is segmented based on product, technique, application, end user, and region. Geographically, North America dominates the global molecular cytogenetics market. Market Analysis and Insights: Global Molecular Cytogenetics Market The global Molecular Cytogenetics…- 世界の細胞遺伝学市場規模・現状・予測（2021年-2027年） Molecular cytogenetics, which is the combination of molecular biology and cytogenetics finds application in the field of biology and medicine. It is used to study the structural and functional organization of chromosomes and nucleus in medicinal and cancer-related genetics. Market Analysis and Insig…
- 世界のIn Situハイブリダイゼーション（ISH）市場規模・現状・予測（2021年-2027年） In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila em…
- 世界のIn-situハイブリダイゼーション（ISH）市場規模・現状・予測（2021年-2027年） In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila em…
- 世界のIn-Situハイブリダイゼーション市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global In-Situ Hybridization Market The global In-Situ Hybridization market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…